Associate Professor, Department of Biochemistry and Synthetic Biology Program,Yong Loo Lin School of Medicine, National University of Singapore;

Director, Singapore Consortium for Synthetic Biology (SINERGY)

Director, Wilmar and NUS Corporate Laboratory (Wil@NUS)

Director, NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI)

Matthew Chang is Director of the Singapore Consortium for Synthetic Biology, Wilmar-NUS Corporate Laboratory and NUS Synthetic Biology for Clinical and Technological Innovation, and Associate Professor in Biochemistry and Synthetic Biology in the Yong Loo Lin School of Medicine at the National University of Singapore. His research focuses on studying the engineering of biology to develop autonomous, programmable cells for grand challenge applications, supported by local and international organizations, and industry. In particular, he has significantly contributed to the development of microbial cells programmed to perform targeted biological functionalities, with over 100 publications and patents. His scientific contributions have been recognised with honours and awards, including the Investigatorship Award from the National Research Foundation of Singapore, and the Scientific and Technological Achievement Award from U.S. Environmental Protection Agency, and have received numerous media recognitions worldwide. He serves as an editor and editorial board member for over 15 leading scientific journals. He has trained over 50 undergraduate and high school students, 20 Ph.D. students and 40 research scientists, many now in leadership roles in academia, government and industry. He is a strong advocate of promoting interdisciplinary science that marries engineering, biological, medical and social sciences through education and public science outreach.